Skip to content

Medicine Matters

Sharing successes, challenges and daily happenings in the Department of Medicine

A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

ARTICLE: A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease AUTHORS: Robert A. Scott, Daniel F. Freitag,… Read More »A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease